Pharmaceutical intermediates

Jingkangen Biomedical provides different types of Pharmaceutical intermediates ranging from milligrams to kilograms scale (1000kg) with high quality and competitive prices.

View More +

Home - Products-JKN Signaling Pathways-D3S-001

D3S-001

CAS:

2914919-85-8

Cat No:

JKN00617

Purity:

98%

Inquire Now + Next Product +

Note: All products of the company are for scientific research only, and do not provide products and services for any individual

Product Description

CAS	2914919-85-8	Cat No	JKN00617
Name	D3S-001
Synonyms	D3S-001
Smiles	CC1=CC(=C(C(=C1C(F)(F)F)[C@@H]2CC3=C(CO2)C(=NC(=N3)OC[C@@]45CCCN4C[C@@H](C5)F)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F)F)N
Chemical Name	2-[(2S)-4-[(7S)-7-[3-amino-2-fluoro-5-methyl-6-(trifluoromethyl)phenyl]-2-[[(2R,8S)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile
Formula	C32H35F6N7O3	MWt	679.7
Purity	98%	Storage	Store at 4--8℃
Description	D3S-001 is under investigation in clinical trial NCT05410145 (A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.g12c Mutation).

Product Documents

Products Category

Wuhan Jingkang en Biomedical Technology Co., Ltd.

Tel: +86 137 2013 4139

E-mail: orders@jknbiochem.com

Add.:Room 2120, Office Building 2, No.1 Baisha Fifth Road, Hongshan District, Wuhan City, Hubei Province, China

Get In Touch